
    
      In this study, 100 professional boxers that experience a concussion will be enrolled,
      randomized to either placebo or sildenafil (60mg) drug treatment, and arterial spin labeling
      and BOLD-MRI with hypercapnia will used to assess CBF and CVR, respectively. Symptom
      reporting, blood biomarkers, and neuropsychological testing will also be conducted. The
      timepoints for this study are baseline (pre-fight), and once between days 1 and 3 and day 30
      after injury.
    
  